The Leadership Team at Artelo Biosciences drives the strategic direction and operational execution of the company’s initiatives in endocannabinoid modulation. Comprising key executives including the CEO, Chief Medical Officer, and Senior Vice Presidents, this team is responsible for overseeing clinical development, financial management, and overall organizational growth to advance the company’s innovative therapeutic programs.
View all